Montelukast dicyclohexylamine
British Pharmacopoeia (BP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 577953-88-9
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 300 MG | BP1147-300-MG | In Stock | ₹ 23,230.45 |
BP1147 - 300 MG
In Stock
Quantity
1
Base Price: ₹ 23,230.45
GST (18%): ₹ 4,181.481
Total Price: ₹ 27,411.931
grade
pharmaceutical primary standard
API family
montelukast
form
solid
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
application(s)
pharmaceuticalpharmaceutical small molecule
format
neat
storage temp.
2-8°C
InChI
1S/C35H36ClNO3S.C12H23N/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39);11-13H,1-10H2/b15-10+;/t32-;/m1./s1
InChI key
ZLOLVGQQYDQBMP-HKHDRNBDSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Montelukast dicyclohexylamine British Pharmacopoeia (BP) Reference Standard | 577953-88-9 | | -- | ₹ 27,583.77 | ||
Sigma Aldrich Fine Chemicals Biosciences Montelukast dicyclohexylamine European Pharmacopoeia (EP) Reference Standard | 577953-88-9 | | -- | ₹ 24,531.07 | ||
Sigma Aldrich Fine Chemicals Biosciences Montelukast dicyclohexylamine United States Pharmacopeia (USP) Reference Standard | 577953-88-9 | 150MG | -- | ₹ 1,58,638.05 | ||
Montelukast dicyclohexylamine | -- | ₹ 1,40,627.58 | ||
Montelukast dicyclohexylamine | -- | ₹ 52,750.23 | ||
Montelukast dicyclohexylamine | -- | ₹ 16,107.60 | ||
577953-88-9 | Montelukast dicyclohexylamine | -- | ₹ 7,565.00 - ₹ 20,381.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Montelukast dicyclohexylamine BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia. Also used in monographs such as:Montelukast Chewable TabletsMontelukast GranulesMontelukast Tablets
- Packaging: Unit quantity: 300 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable